Lead sponsor

National and Kapodistrian University of Athens

4 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

4

Trials led

2

Active

410

Total enrollment

4

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1
Not applicable
3

Trials by status

Recruiting
2
Completed
1
Unknown
1

Trials led

DiagenixBMI ≥40not applicableRecruiting220
NAMELS-18not applicableCompleted78
TiLi-BONEBMI ≥40not applicableRecruiting72